secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001493152-25-012778
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow launches $250M senior notes offering, enters $40M revolver, and discloses Melt Pharmaceuticals acquisition plan
--------------------------------------------------------------------------------

- Launched $250M offering of senior unsecured notes due 2030 to refinance existing debt, including redemption of 2026 Notes (8.625%, $75M) and 2027 Notes (11.875%, $40.25M).
- Entered commitment for $40M revolving credit facility with Fifth Third Bank, secured by substantially all assets, maturing 91 days before 2030 Notes maturity or five years from closing.
- Issued conditional notice to redeem all $40.25M 2027 Notes at 102% of par plus accrued interest on Oct 9, 2025, contingent on completion of the Offering.
- Plans to redeem $75M 2026 Notes at 100% plus make-whole, and repay $107.5M Oaktree loan, with remaining proceeds for general corporate purposes.
- Disclosed non-binding LOI to acquire remaining 55% of Melt Pharmaceuticals for ~$4.3M cash at close plus contingent milestones; CEO and CFO hold Melt interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315225012778/0001493152-25-012778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315225012778/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer